Is it time for routine EEG monitoring after intracerebral hemorrhage?
Fountain
Nathan B
NB
D000927:Anticonvulsants / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D002543:Cerebral Hemorrhage / Q000150:complications* / Q000503:physiopathology; D003362:Cost-Benefit Analysis; D004569:Electroencephalography / Q000191:economics / Q000592:standards*; D006801:Humans; D008991:Monitoring, Physiologic / Q000191:economics / Q000379:methods / Q000592:standards; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D012640:Seizures / Q000175:diagnosis* / Q000209:etiology* / Q000503:physiopathology; D013226:Status Epilepticus / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control
D000927:Anticonvulsants